Business Description

Takara Holdings incorporates manages its subsidiaries. The company was established in September 1925 and is headquartered in Kyoto, Japan. Takara Bio Inc.’s parent company is Takara Holdings Inc. The company operates in the following segments: Takara Bio Group, Takara Shuzo International, Takara Shuzo, and Others.

The Takara Bio Group segment specializes in contract research, research reagents, gene therapy, and scientific instruments. The Other segment covers logistics companies and real estate leasing. The Takara Shuzo segment sells and produces Japanese alcoholic beverages. Takara Shuzo International exports Japanese liquor Japanese foodstuff and wholesalers.

Key Financials

Revenue (US$ Mn)

• US$ 2,527 Mn was the annual revenue generated by Takara Holdings in 2021
• Takara Holdings’s annual revenue for 2020 was US$ 2,614 Mn, a 0.95% increase from 2019
• From 2018’s annual revenues, Takara Holdings registered a 3.31% increase in 2019, amounting to US$ 2,590 Mn
• Total revenue of US$ 2,507 Mn was generated in 2018 by Takara Holdings

Operating Income (US$ Mn)

• Takara Holdings’s operating income for 2021 was US$ 196 Mn, a -3.38% decrease from 2020
• The operating income generated by Takara Holdings in 2020 was US$ 203 Mn
• At a -9.33% decrease, Takara Holdings’s operating income of US$ 146 Mn was indexed in 2019
• Takara Holdings generated an operating income of US$ 161 Mn in 2018

Net Income (US$ Mn)

• US$ 96 Mn was Takara Holdings’s net income in 2021, a -3.42% decrease from 2020 figures
• Takara Holdings indexed a 20.07% increase in net incomes from 2019, amounting to US$ 99 Mn in 2020
• Takara Holdings generated a net income of US$ 83 Mn in 2019
• A net income of US$ 94 Mn was indexed by Microsoft Corporation in 2018

Operating Margin %

• 8% was the operating margin generated by Takara Holdings in 2021
• Takara Holdings’s operating margin for 2020 was 8%, a 39.29% increase from 2019
• From 2018’s operating margins, Takara Holdings registered a -12.5% decrease in 2019, amounting to 6%
• An operating margin of 6% was generated in 2018 by Takara Holdings

Gross Margin%

• Takara Holdings’s gross margin for 2021 was 4%, a 0% decrease from 2020
• The gross margin generated by Takara Holdings in 2020 was 4%
• At a -14.93% decrease, Takara Holdings’s gross margin of 3% was indexed in 2019
• Takara Holdings generated a gross margin of 4% in 2018

SWOT Analysis

Strengths

Focus on Biotechnology Research

Through constant product development, the company strives to strengthen its biotechnology research. Takara Bio is a pioneer in biomedical technology, including cell medicine and gene therapy. This segment is made up of three divisions in biomedical: the bio-industry, gene therapy, and agribio businesses. The bio-industry company develops and sells scientific instruments and research reagents, such as high-function PCR enzymes or real-time PCR systems for gene amplification. This business provides value-added services like high-speed sequence analysis, contract production, and services for iPSCs.

Gene therapy is a business that engages in in-house cell and gene therapy development for cancer and other diseases. It uses its core gene engineering and gene technology technologies. Agri-bio analyzes traditional Japanese foodstuffs using its biotechnology. This information is used to create and manufacture healthy food products. Takara Bio uses its technology for large-scale mushroom cultivation and breeding. Takara Bio’s R&D focuses on products in both the genetic engineering and regenerative medicine research fields.

It aims to expand the industrial application of PCR-related technology (applied fields) and to develop new products that are related to next-generation sequencing. Takara Bio will develop new products and services in the regenerative medicine area. The group’s strong focus on biotechnology research allows them to maintain technological leadership in all of their product segments. This allows Takara to create innovative products that result in strong sales.

Get this premium content

The Premium data is Locked

Buy Now to Unlock Premium Data

Request Sample Data